Structure-guided computational design and mechanistic understanding of the p95HER2-targeting NAZ-mAb antibody and its variants
A practical framework for computationally driven, developability-aware antibody optimization in the absence of experimental structural data is provided and shows that the computational workflow can generate experimentally tractable, antigen-engaging NAZ-mAb variants, while also highlighting the limitations of fixed-bac...